Información del autor
Autor Ugarte-Gil, Cesar |
Documentos disponibles escritos por este autor (25)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Kirwan, Daniela E. ; Ugarte-Gil, Cesar ; Gilman, Robert H. ; Caviedes, Luz ; Rizvi, Hasan ; Ticona, Eduardo ; Chavez, Gonzalo ; Cabrera, Jose Luis ; Matos, Eduardo D. ; Evans, Carlton A. ; Moore, David A. J. ; Friedland, Jon S. ; Lymph Node TB Working Group | American Society for Microbiology | 2019-02-06T14:52:38ZIn this study, 132 patients with lymphadenopathy were investigated. Fifty-two (39.4%) were diagnosed with tuberculosis (TB). The microscopic observation drug susceptibility (MODS) assay provided rapid (13 days), accurate diagnosis (sensitivity, [...]texto impreso
Millard, James ; Ugarte-Gil, Cesar ; Moore, David A. J. | BMJ Publishing Group | 2019-02-06T14:59:05Ztexto impreso
Ong, Catherine W. M. ; Elkington, Paul T. ; Brilha, Sara ; Ugarte-Gil, Cesar ; Tome-Esteban, Maite T. ; Tezera, Liku B. ; Pabisiak, Przemyslaw J. ; Moores, Rachel C. ; Sathyamoorthy, Tarangini ; Patel, Vimal ; Gilman, Robert H. ; Porter, Joanna C. ; Friedland, Jon S. | Public Library of Science | 2019-02-06T14:53:12ZPulmonary cavities, the hallmark of tuberculosis (TB), are characterized by high mycobacterial load and perpetuate the spread of M. tuberculosis. The mechanism of matrix destruction resulting in cavitation is not well defined. Neutrophils are e[...]texto impreso
Lambert, Allison A. ; Lam, Jennifer O. ; Paik, Julie J. ; Ugarte-Gil, Cesar ; Drummond, M. Bradley ; Crowell, Trevor A. | Public Library of Science | 2019-02-06T14:53:10ZBACKGROUND: Proton-pump inhibitors (PPIs) are among the most frequently prescribed medications. Community-acquired pneumonia (CAP) is a common cause of morbidity, mortality and healthcare spending. Some studies suggest an increased risk of CAP a[...]texto impreso
Saldanha, Ian J. ; Li, Tianjing ; Yang, Cui ; Ugarte-Gil, Cesar ; Rutherford, George W. ; Dickersin, Kay | Elsevier | 2019-02-06T14:52:38ZOBJECTIVES: Methods to develop core outcome sets, the minimum outcomes that should be measured in research in a topic area, vary. We applied social network analysis methods to understand outcome co-occurrence patterns in human immunodeficiency v[...]texto impreso
Carrasco-Escobar, Gabriel ; Schwalb, Alvaro ; Tello-Lizarraga, Kelly ; Vega-Guerovich, Percy ; Ugarte-Gil, Cesar | BMC | 2020-07-14T00:01:00ZGrowing evidence suggests pollution and other environmental factors have a role in the development of tuberculosis (TB), however, such studies have never been conducted in Peru. Considering the association between air pollution and specific geog[...]texto impreso
Gianella, Camila ; Ugarte-Gil, Cesar ; Caro, Godofredo ; Aylas, Rula ; Castro, Cesar ; Lema, Claudia | Harvard University Press | 2019-02-06T14:45:34ZThis article analyzes the factors associated with vulnerability of the Ashaninka, the most populous indigenous Peruvian Amazonian people, to tuberculosis (TB). By applying a human rights-based analytical framework that assesses public policy ag[...]texto impreso
Gianella, Camila ; Pesantes, M. Amalia ; Ugarte-Gil, Cesar ; Moore, David A. J. ; Lema, Claudia | BMC | 2019-12-06T20:57:42ZBACKGROUND: In 2014 the World Health Organization (WHO) launched the "End TB Strategy", setting new ambitious goals for elimination of tuberculosis (TB). In contrast with previous efforts to control TB, the new strategy adopted the protection an[...]texto impreso
Gianella, Camila ; Pesantes, M. Amalia ; Ugarte-Gil, Cesar ; Moore, David A. J. ; Lema, Claudia | BMC | 2019-07-04T17:01:24ZBackground. In 2014 the World Health Organization (WHO) launched the “End TB Strategy”, setting new ambitious goals for elimination of tuberculosis (TB). In contrast with previous efforts to control TB, the new strategy adopted the protection an[...]texto impreso
Lazo-Porras, Maria ; Prutsky, Gabriela J. ; Barrionuevo, Patricia ; Tapia, Jose Carlos ; Ugarte-Gil, Cesar ; Ponce, Oscar J. ; Acuna-Villaorduna, Ana ; Domecq, Juan Pablo ; De la Cruz-Luque, Celso ; Prokop, Larry J. ; Malaga, German | BMC | 2020-07-14T00:02:31ZBACKGROUND: To evaluate the effectiveness and safety of the World Health Organization antibiotic regimen for the treatment of paucibacillary (PB) and multibacillary (MB) leprosy compared to other available regimens. METHODS: We performed a searc[...]